Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs
- 31 March 2002
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (3) , 331-334
- https://doi.org/10.1016/s1081-1206(10)62017-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactionsAnnals of Allergy, Asthma & Immunology, 2001
- Meloxicam in hypersensitivity to NSAIDsAllergy, 2001
- Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma☆Journal of Allergy and Clinical Immunology, 2001
- Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugsAnnals of Allergy, Asthma & Immunology, 2000
- Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regionsBritish Journal of Clinical Pharmacology, 1999
- Aspirin-induced asthma: Advances in pathogenesis and management☆☆☆Journal of Allergy and Clinical Immunology, 1999
- COX-2 inhibitorsThe Lancet, 1999
- Floctafenine: a Valid Alternative in Patients with Adverse Reactions to Nonsteroidal Anti-inflammatory DrugsAnnals of Allergy, Asthma & Immunology, 1997
- A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymesTrends in Pharmacological Sciences, 1997
- Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-[125I]iodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active SiteJournal of Biological Chemistry, 1996